15 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
module in AUTO6NG.
Host Immune System Recruitment (ssIL12)
IL-12 is a potent anti-tumor cytokine that mediates the activity of many different anti-tumor … ”), referred to as the FELIX trial. Recruitment in the Phase 2 Cohort A of the FELIX trial for morphological adult r/r ALL patients has been completed
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
13 Feb 24
Regulation FD Disclosure
4:06pm
) Host Immune Cell Recruitment (ssIL12) Engineering survival signal (Fas-TNFR) AUTO4 AUTO5 AUTO6NG AUTO9 AUTO6NG AUTO6NG Private & Confidential
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
where special circumstances apply or where recruitment or retention of a particular executive director is required.
AUTOLUS THERAPEUTICS PLC … -in-kind are provided to support executive directors in carrying out their duties and assist with retention and recruitment.
The Company aims to offer
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
compensation consultant. The Committee may vary from this general philosophy where special circumstances apply or where recruitment or retention … and assist with retention and recruitment.
The Company aims to offer benefits that are in line with market practice.
The benefits currently available
6-K
EX-1
yn0zhh3 1qgzo
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
unsb87e
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
xca5pvynmsx5 n42relj
23 Nov 18
Annual report (foreign)
12:00am
424B4
gxav2ky4d
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
mhvmun2715gtgk0z g9
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
cszomy o02ozynt83r5
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
rbv 4byl8ovu1hv97
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
051xnho
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next